Results 41 to 50 of about 1,075 (151)

Safety monitoring of treatment in bipolar disorder in a tertiary care setting in Sri Lanka and recommendations for improved monitoring in resource limited settings

BMC Psychiatry, 2019
Background Safety monitoring of medicines is essential during therapy for bipolar disorder (BD). We determined the extent of safety monitoring performed according to the International Society for Bipolar Disorders (ISBD) guidelines in patients with BD ...
Uthpali Mannapperuma, Priyadarshani Galappatthy, Raveendra Laal Jayakody, Jayan Mendis, Varuni Asanka de Silva, Raveen Hanwella   +5 more
doaj   +1 more source

Association Between Adherence Barriers, Self‐Reported Adherence, and Psychiatric Symptoms Among Adults With Bipolar Disorder

Bipolar Disorders, Volume 27, Issue 8, Page 567-577, December 2025.
ABSTRACT Aims While suboptimal medication adherence is a widely recognized problem for people with bipolar disorder (BD), it is less clear how individual characteristics are associated with varying levels of adherence and how specific adherence barriers impact behaviors.
Martha Sajatovic, Jennifer B. Levin, Clara Adeniyi, Jessica Black, Celeste Weise, Nicole Fiorelli, Erika Kelley, Doug Einstadter, Mark Bauer, Farren B. S. Briggs   +9 more
wiley   +1 more source

Do Patients Comply With 12‐h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real‐World Clinical Setting

Bipolar Disorders, Volume 27, Issue 7, Page 519-526, November 2025.
ABSTRACT Background Lithium blood levels are measured routinely 12 h after lithium dosing, but no study has evaluated the actual compliance of patients with the 12‐h levels. Methods First, we used the US multicenter clinical trial “Bipolar CHOICE” (n = 145 patients treated with lithium with N = 287 lithium blood tests), where participants reported the ...
Søren L. Jacobsen, Christian L. Kraft, Andrew A. Nierenberg, Torben A. Devantier, Ole Köhler‐Forsberg   +4 more
wiley   +1 more source

Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 688-701, October 2025.
ABSTRACT Depression is the leading cause of disability worldwide, affecting people of all ages. Both pharmacological and non‐pharmacological therapies are available for its treatment. However, some patients do not respond to first‐line pharmacological interventions, referred to as treatment‐resistant depression (TRD).
Angela Acero‐González, Yahira Guzman, Nadia Juliana Proaños, Rosa‐Helena Bustos, María Aconcha, Ivan Guerrero, Laura Alejandra Martinez, Michael Berk, Seetal Dodd   +8 more
wiley   +1 more source

INTERNATIONAL STANDARD BIBLIOGRAPHIC DESCRIPTION (ISBD) AS STANDARD FOR QUALITY BOOK PUBLISHING IN NIGERIA

Brazilian Journal of Information Science, 2011
This study examines international standard bibliographic description (ISBD) as standard for quality book publishing in Nigeria. It discusses ISBD as it affects quality book publishing.
Eboro E. Umoren, Uduak U. Enang
doaj  

Standartinių bibliotekų metaduomenų modelių ir struktūrų pateikimo semantiniame saityne iniciatyvos

Aktualu Rytoj, 2013
Straipsnyje aptariamos naujausios bibliotekų metaduomenų modelių ir struktūrų, tarp jų – IFLA standartų „Functional Requirements for Bibliographic Records“ (FRBR) („Funkciniai reikalavimai bibliografiniams įrašams“), „Functional Requirements for ...
Gordon Dunsire, Mirna Willer
doaj   +1 more source

The Validity and Reliability Study of the Turkish Version of Cognitive Complaints in Bipolar Disorder Rating Assessment

International Journal of Methods in Psychiatric Research, Volume 34, Issue 3, September 2025.
ABSTRACT Objectives The Cognitive Complaints Rating Scale in Bipolar Disorder (COBRA) is a brief self‐report measure designed to capture Subjective Cognitive Complaints (SCC) experienced by patients with Bipolar Disorder (BD). This study aimed to translate the 16‐item COBRA into Turkish (COBRA‐TR) and comprehensively assess its psychometric properties.
Ezgi Ince Guliyev, Gulcan Karaca Ozkutuk, Sema Cagal, Ece Ozlem Ozturk, Tugay Elik, Nupelda Akdas, Cem Horasan, Sibel Cakır, Nese Direk, Omer Aydemir   +9 more
wiley   +1 more source

Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force

Bipolar Disorders, 2019
Impairments in affective cognition are part of the neurocognitive profile and possible treatment targets in bipolar disorder (BD), but the findings are heterogeneous.
K. Miskowiak, I. Seeberg, H. Kjaerstad, K. Burdick, A. Martínez-Àran, C. Bonnin, C. Bowie, A. Carvalho, P. Gallagher, G. Hasler, B. Lafer, C. López-Jaramillo, T. Sumiyoshi, R. McIntyre, A. Schaffer, R. Porter, S. Purdon, I. Torres, L. Yatham, A. Young, L. Kessing, T. V. Van Rheenen, E. Vieta   +22 more
semanticscholar   +1 more source

Socio-demographic and clinical predictors of outcome to long-term treatment with lithium in bipolar disorders: a systematic review of the contemporary literature and recommendations from the ISBD/IGSLI Task Force on treatment with lithium

International Journal of Bipolar Disorders, 2020
Objective To identify possible socio-demographic and clinical factors associated with Good Outcome (GO) as compared with Poor Outcome (PO) in adult patients diagnosed with Bipolar Disorder (BD) who received long-term treatment with lithium.
D. Grillault Laroche, B. Étain, E. Severus, Jan Scott, F. Bellivier   +4 more
semanticscholar   +1 more source

RDA: the Emperor’s New Code

JLIS.it, 2016
Argues that the RDA was an unnecessary waste of time and money. The few improvements it makes in catalogue records could have been accomplished far more cheaply, promptly, and easily by modifying AACR2.
Michael Gorman
doaj   +6 more sources